Rosen H, Muhlestein J B, Bartlett J, Chen S, Chikami G, Corson M, Shah P K, Gurfinkel E, Handsfield H, Jackson L, Knirsch C, Kronmal R, McCutchan J A, Shea S
Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA.
J Infect Dis. 2000 Jun;181 Suppl 3:S582-4. doi: 10.1086/315597.
The task assigned to the working group on Clinical Antimicrobial Trials for Primary and/or Secondary Prevention of Atherosclerotic Cardiovascular Disease was to evaluate the need for additional clinical antibiotic trials of a primary or secondary nature for the treatment of atherosclerotic heart disease and to suggest possible designs for future trials. In addition, the working group was to define the role of collaboration in answering research questions.
分配给动脉粥样硬化性心血管疾病一级和/或二级预防临床抗菌试验工作组的任务是评估是否需要开展更多针对动脉粥样硬化性心脏病治疗的一级或二级性质的临床抗生素试验，并为未来试验提出可能的设计方案。此外，该工作组还需明确合作在回答研究问题方面的作用。
